Status:
COMPLETED
Evaluation of the Mechanism of Action of Platelet Rich Fibrin Matrix (PRFM) in Producing Skin Volume Augmentation
Lead Sponsor:
The New York Eye & Ear Infirmary
Conditions:
Aging
Eligibility:
All Genders
25-75 years
Phase:
PHASE1
PHASE2
Brief Summary
Autologous platelet rich fibrin matrix will release growth factors which could increase the production of dermal proteins or affect the vascularity and status of neighboring tissues. This study is des...
Detailed Description
Subjects will be treated with platelet rich fibrin matrix into the skin of the inner aspect of the upper arm. Injected areas will be monitored clinically and will also undergo biopsies between 30 minu...
Eligibility Criteria
Inclusion
- 25 and 75 years of age
Exclusion
- collagen vascular disorders
- autoimmune diseases
- signs or history of impaired wound healing
- shall not have had any infectious or inflammatory processes at the treatment sites within the prior 6 months
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT00956020
Start Date
October 1 2009
End Date
July 1 2011
Last Update
December 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The NY Eye & Ear Infirmary
New York, New York, United States, 10003